Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
MindBio Therapeutics Corp., a key player in psychiatric medicine, has announced a private placement to issue listed securities aiming to raise up to CAD$200,000. The funds will support their ongoing Phase 2B trials, expected to complete in 2025, marking a significant step towards enhancing mental health treatments.
For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.
